Pentatricopeptide repeat (PPR) technology can precisely edit Both RNA and DNA. Free of CRISPR’s intellectual property mire, this system could revolutionize gene therapy. What started as a quest ...

With its strategic positioning and planned enhancements, this latest addition is poised to support PPR’s goal of delivering long-term value for its investors.